TREM2 and Alzheimer disease: Taken together, TREM2 deficiency significantly activated FoxO3a (having less p-FoxO3a) and increased the amyloid plaques, suggesting FoxO3a may participate in TREM2-mediated AD pathology in the transgenic mice.